CAS 1155773-15-1

ER 819762

CAS: 1155773-15-1

ER 819762 is a potent anticancer drug that targets the cell cycle and induces apoptosis in human cancer cells. It is a kinase inhibitor that has been shown to be effective against a variety of cancers, including leukemia. ER 819762 works by blocking the activity of specific proteins involved in cell growth and division, which ultimately leads to cell death. This drug has been isolated from Chinese medicinal plants and shows promising potential as a new treatment for cancer. In addition to its anticancer properties, ER 819762 may also have other therapeutic applications due to its ability to inhibit protein function. Overall, ER 819762 is an exciting new development in cancer research with the potential to revolutionize cancer treatment.

Fórmula: C₃₀H₃₉N₃O₃

Pureza: Min. 95%

Peso molecular: 489.6 g/mol

Ref: 3D-FWB77315

ER819762

CAS: 1155773-15-1

ER819762, an antagonist of the prostaglandin E2 EP4 receptor, inhibits Th1 differentiation and Th17 expansion.

Fórmula: C₃₀H₃₉N₃O₃

Forma y color: Solid

Peso molecular: 489.65

Ref: TM-T27279